- Home
- FCNCP vs ZTEK Comparison
FCNCP vs ZTEK Comparison
Compare FCNCP & ZTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FCNCP | ZTEK |
|---|---|---|
| Founded | N/A | 2008 |
| Country | United States | Canada |
| Employees | 18141 | N/A |
| Industry | Major Banks | Major Chemicals |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | 68.8M |
| IPO Year | N/A | 2022 |
Fundamental Metrics
Financial Performance| Metric | FCNCP | ZTEK |
|---|---|---|
| Price | $21.24 | $0.54 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 14.8K | ★ 122.1K |
| Earning Date | N/A | 02-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $19.30 | $0.54 |
| 52 Week High | $22.86 | $1.84 |
Technical Indicators
Market Signals| Indicator | FCNCP | ZTEK |
|---|---|---|
| Relative Strength Index (RSI) | 46.68 | 29.59 |
| Support Level | $20.82 | N/A |
| Resistance Level | $21.33 | $0.75 |
| Average True Range (ATR) | 0.24 | 0.04 |
| MACD | -0.02 | -0.01 |
| Stochastic Oscillator | 54.23 | 5.07 |
Price Performance
Historical ComparisonAbout FCNCP First Citizens BancShares Inc.
First Citizens BancShares Inc. is a Raleigh, N.C.-based financial holding company operating through its subsidiary, First-Citizens Bank & Trust Company. It provides comprehensive retail banking, commercial lending, leasing, and wealth management services via a nationwide branch network and digital platforms. In 2023 acquisition of Silicon Valley Bank, it also specializes in banking for tech, healthcare, and innovation firms.
About ZTEK Zentek Ltd.
Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.